Related Experiment Video
Updated: Nov 18, 2025

Murine Heterotopic Heart Transplant Technique
Published on: July 8, 2014
Heart Retransplantation From an Hepatitis B Core Antibody (Anti-HBcore)-Positive Donor: A Case Report
Agnieszka Kuczaj1, Szymon Warwas2, Piotr Przybyłowski3
1Department of Cardiac, Vascular, and Endovascular Surgery and Transplantology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Zabrze, Poland.
Insights
Heart retransplantation using Hepatitis B core antibody-positive donors is a safe option for seronegative recipients when managed with antiviral prophylaxis. This approach can help address donor shortages in urgent heart transplantation cases.
Area of Science:
- Cardiology
- Transplantation Immunology
- Infectious Diseases
Background:
- End-stage heart failure necessitates heart transplantation, but donor shortages, especially for urgent cases, remain a significant challenge.
- Extended-criteria donors are being considered to increase organ availability.
- Hepatitis B virus (HBV) serological markers, such as anti-HBcore positivity, can influence donor selection.
Abstract:
Heart transplantation is performed in patients with end-stage heart failure. The number of suitable donors for patients on the urgent heart transplantation waiting list is still low, and effort has been made to increase the number of suitable donors, including extended-criteria donors. We present a case report of heart retransplantation because of graft failure from an hepatitis B core antibody (anti-HBcore-positive, HBcAb [+]) and HBs antigen-negative (HBsAg [-]) donor to a seronegative recipient. We show that the procedure, with the use of antiviral prophylaxis, is a safe option for the recipient. Based on anatomopathologic and histopathologic examination of the explanted graft, we also suggest that acute cellular rejection in the transplanted heart may exist despite negative findings in right-sided endomyocardial biopsy.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction

